One page, thousands of outlets. See who else covered it.
These two stocks both have market caps of more than $1 trillion, but Eli Lilly's valuation is supported by strong financials.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
VEA targets developed markets with lower costs and stronger recent returns, while IXUS offers broader exposure to 4,476 companies including emerging markets.
Equity Bank Holdings has posted a 32 per cent growth in net earnings for the first six months of the year, boosted by rising contributions from its regional subsidiaries.
HCV regimen met non-inferiority with 8-week dosing for non-cirrhotic patients.
Revenue surged 26% as Peru and Colombia markets accelerated with 100% occupancy.
Core revenue grew 16% year over year as government contracts accelerated.